Stock Ticker

  • Loading stock data...

DURECT Corporation (NASDAQ:DRRX) And Indivior UK Limited Sign A Patent Purchase Agreement

DURECT Corporation (NASDAQ:DRRX) reported a patent purchase deal with Indivior UK Limited, an associate of Indivior PLC, whereby DURECT has given certain of its U.S. patent privileges to Indivior. This assignment may offer further IP protection for RBP-7000. The details Indivior reported that it has filed a New Drug Application for RBP-7000 to the U.S. […]

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Showcases Results From trial Examining Patient and Physician Experiences And Perceptions With IBS-C

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) reported new findings showcasing the frustration of patients suffering from IBS-C and the viewpoint of healthcare providers who cure these patients. The web questionnaire, intended to advance a better understanding of the attitudes and experiences associated with IBS-C, disclosed numerous patients experienced lost productivity and stress when managing this problem. HCPs […]

What Is Going On With Atossa Genetics Inc (NASDAQ:ATOS)?

Atossa Genetics Inc (NASDAQ:ATOS) a clinical-stage pharmaceutical firm developing novel delivery methods and therapeutics for breast cancer and other breast problems, reported that the Ernest Mario School of Pharmacy at Rutgers, intends to plan a study using company’s intraductal microcatheter technology. The details The Rutgers researchers consider that directly administering medications into the breast duct, […]

What Is The Buzz Surrounding Dextera Surgical Inc (NASDAQ:DXTR)?

Dextera Surgical Inc (NASDAQ:DXTR) reported that numerous major surgeons featured the application of Dextera Surgical’s MicroCutter 5/80™ Stapler as well as its C-Port® Distal Anastomosis Systems in distinct oral presentations at the recently held Annual European Association for Cardio-Thoracic Surgery. The highlights Liam Burns, the VP Global Sales and Marketing at Dextera Surgical, expressed that […]

Neothetics Inc (NASDAQ:NEOT) Announces Merger Deal With Evofem Biosciences, Inc.

Evofem Biosciences, Inc. and Neothetics Inc (NASDAQ:NEOT) have finalized a definitive deal under which the former firm will merge with a 100% owned subsidiary unit of Neothetics in an all-stock deal. The merger will place the combined firm with a prospect to become a major women’s health firm that commercializes and develops novel offerings. Upon […]

Transenterix Inc (NYSEAMERICAN:TRXC) Reports US 510(k) FDA Approval For Senhance Surgical Robotic System

Transenterix Inc (NYSEAMERICAN:TRXC) reported that the firm has obtained FDA 510(k) approval for the Senhance™ Surgical Robotic System. Todd M. Pope, the CEO and President, expressed that the clearance of the Senhance System in the United States is a milestone in the advancement of robotics and is anticipated to deliver improvement in the value, efficacy […]

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Reports Completion Of TIVO-3 Trial Futility Analysis

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) reported the conclusion of a pre-planned futility assessment of the Phase III TIVO-3 study, the firm’s randomized, controlled, open-label trial to compare FOTIVDA® to sorafenib in people with refractory advanced RCC. Dependent on the data of the futility assessment, which was assessed by an independent statistician, the trial will continue as […]

Capricor Therapeutics Inc (NASDAQ:CAPR) Progresses With Its Lead Investigational Product

Capricor Therapeutics Inc (NASDAQ:CAPR) in a poster presentation released report which support the peripheral intravenous administration method the firm intends to use in HOPE-2, its intended next clinical study of its lead investigational offering, CAP-1002, for the cure of Duchenne muscular dystrophy. The details CAP-1002 comprises of allogeneic cardiosphere-derived cells, whose mechanism of action is […]

Why The Focus Is On ImmunoCellular Therapeutics Ltd (NYSEAMERICAN:IMUC)?

Traders News Source released a report with no obligation on ImmunoCellular Therapeutics Ltd (NYSEAMERICAN:IMUC), a firm that is advancing immune-based therapies targeting brain diseases and other cancers. The firm is focusing resources on developing its research-stage Stem-to-T-Cell plan in collaboration with major academic researchers and contract labs. It is also continuing to assess opportunities to […]

TrovaGene Inc (NASDAQ:TROV) Strengthens Board With Appointment Of Dr. Athena Countouriotis

TrovaGene Inc (NASDAQ:TROV) reported the strengthening and expansion of its Board with the election of Athena Countouriotis, M.D., who brings extensive experience leading clinical advancement programs, from preclinical through clinical phases, and approval. During the course of her career, Dr. Countouriotis has been involved in numerous clinical plans, with a focus within oncology that have […]

Cytori Therapeutics Inc (NASDAQ:CYTX) Reports Corporate Restructuring And Cost Reduction Plan

Cytori Therapeutics Inc (NASDAQ:CYTX) reported a substantial corporate restructuring planned to significantly lower expenses while maintaining its ability to implement on its BARDA-sponsored cell therapy plan, Japanese business and oncology plan The Cytori Habeo plan for scleroderma is anticipated to move forward depending on feedback from its upcoming meetings with the U.S. FDA and PMDA […]

What Is The Buzz Surrounding Zymeworks Inc (NYSE:ZYME)?

Zymeworks Inc (NYSE:ZYME) reported that Merck, also termed as MSD outside the United States and Canada has released formal notification of their plans to develop a bispecific drug candidate into preclinical advancement. The drug candidate was advanced by Merck, through a subsidiary, together with Zymeworks utilizing Zymeworks’ proprietary EFECT™ and Azymetric™ platforms as part of […]

Avinger Inc (NASDAQ:AVGR) Gets CE Marking Nod For In-Stent Restenosis Treatment Indication

Avinger Inc (NASDAQ:AVGR) a key developer of unique treatments for Peripheral Artery Disease reported Conformité Européenne Marking approval for curing in-stent restenosis using the Pantheris® Lumivascular atherectomy system. The details In-stent restenosis happens when an earlier blocked artery cured with a stent becomes narrowed again, obstructing blood flow. Doctors often face challenges when curing in-stent […]

MannKind Corporation (NASDAQ:MNKD) Releases Update On Afrezza® Prescribing Information

MannKind Corporation (NASDAQ:MNKD) reported that the U.S. Food & Drug Administration has approved a revision to the Afrezza prescribing information to constitute new clinical data that was showcased at the 76th Scientific Sessions of American Diabetes Association in June 2016. Afrezza inhalation powder is permitted by the FDA to enhance glycemic control in adults with […]

Sign Up To Get Our Latest Stocks Alerts